Skip to main content
SpringerLink
Log in

Ethics

  • Chapter
  • First Online:
Clinical Dermatology Trials 101

Abstract

“First, do no harm”—an apt description of one of medicine’s central tenets. So too in dermatology does this platitude apply. But in addition to simply doing no physical harm, the field of dermatology follows principles that extend beyond just the physical health of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lo B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. N Engl J Med. 2000;343(22):1616–20.

    Article  CAS  PubMed  Google Scholar 

  2. Freiman A, Natsheh A, Barankin B, Shear NH. Dermatology postgraduate training in Canada: CanMEDS competencies. Dermatol Online J. 2006;12(1):6.

    PubMed  Google Scholar 

  3. Bercovitch L, Long TP. Dermatoethics: a curriculum in bioethics and professionalism for dermatology residents at Brown Medical School. J Am Acad Dermatol. 2007;56(4):679–82.

    Article  PubMed  Google Scholar 

  4. Bercovitch L, Long TP. Ethics education for dermatology residents. Clin Dermatol. 2009;27(4):405–10.

    Article  PubMed  Google Scholar 

  5. Markman JR, Markman M. Running an ethical trial 60 years after the Nuremberg Code. Lancet Oncol. 2007;8(12):1139–46.

    Article  PubMed  Google Scholar 

  6. Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Vol. 2 ed. Washington, DC: U.S. Government Printing Office; 1949.

    Google Scholar 

  7. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277(11):925–6.

    Article  Google Scholar 

  8. Beauchamp T, Childress J. Principles of biomedical ethics. 5th ed. New York: Oxford University Press; 2001.

    Google Scholar 

  9. Hornblum A. Acres of skin: human experiments at Holmesburg Prison. 1st ed. New York: Routledge; 1998.

    Google Scholar 

  10. Gellene D. Dr. Albert M. Kligman, Dermatologist, Dies at 93. New York Times 2010;US:A25.

    Google Scholar 

  11. Naedele W. ALBERT M. KLIGMAN, 1916–2010 Penn inventor of Retin-A, criticized for test method. 2010. http://articles.philly.com/2010-02-21/news/25219222_1_retin-albert-m-kligman-prisoners. Accessed 03 Nov 2014.

    Google Scholar 

  12. Tannen RL. The ethical issues of the Holmesburg studies have been addressed. Arch Dermatol. 2000;136(2):268.

    Article  CAS  PubMed  Google Scholar 

  13. Arboleda-Florez J. The ethics of biomedical research on prisoners. Curr Opin Psychiatry. 2005;18:514–7.

    Article  PubMed  Google Scholar 

  14. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research; 1979.

    Google Scholar 

  15. Lilford RJ. Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ. 2003;326(7396):980–1.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Gifford F. Community-equipoise and the ethics of randomized clinical trials. Bioethics. 1995;9(2):127–48.

    Article  PubMed  Google Scholar 

  17. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005;294(17):2203–9.

    Article  CAS  PubMed  Google Scholar 

  18. Castanedo-Tardan MP, Baumann L. Ethics of selling skin care. Clin Dermatol. 2009;27(4):355–8.

    Article  PubMed  Google Scholar 

  19. American Medical Association Code of Ethics: Opinion 8.063—Sale of Health-Related Products from Physicians’ Offices. 2000. http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion8063.page. Accessed 15 Dec 2013.

  20. American Academy of Dermatology. Ethics in Medical Practice with Special Reference to Dermatology. 2012.

    Google Scholar 

  21. Morin K, Rakatansky H, Riddick Jr FA, Morse LJ, O’Bannon 3rd JM, Goldrich MS, et al. Managing conflicts of interest in the conduct of clinical trials. JAMA. 2002;287(1):78–84.

    Article  PubMed  Google Scholar 

  22. Newburger AE, Caplan AL. Taking ethics seriously in cosmetic dermatology. Arch Dermatol. 2006;142(12):1641–2.

    Article  PubMed  Google Scholar 

  23. Rundle R. A new name in skin care: Johns Hopkins. The Wall Street Journal 2006 Apr 5;B1 (Eastern Edition).

    Google Scholar 

  24. Jarrell A. Doctors who love publicity. New York Times 2000 Jul 2; 2013 Dec 15.

    Google Scholar 

  25. Williams HC, Seed P. Inadequate size of ‘negative’ clinical trials in dermatology. Br J Dermatol. 1993;128(3):317–26.

    Article  CAS  PubMed  Google Scholar 

  26. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701–11.

    Article  CAS  PubMed  Google Scholar 

  27. Halpern SD, Karlawish JH, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA. 2002;288(3):358–62.

    Article  PubMed  Google Scholar 

  28. Greenberg RD. The American Academy of Dermatology Ethics Committee: how it works and what you need to know. Clin Dermatol. 2009;27(4):331–5.

    Article  PubMed  Google Scholar 

  29. Angell M. The ethics of clinical research in the Third World. N Engl J Med. 1997;337(12):847–9.

    Article  CAS  PubMed  Google Scholar 

  30. Payette M, Grant-Kels JM. Brand name versus generic drugs: the ethical quandary in caring for our sophisticated patients while trying to reduce health-care costs: facts and controversies. Clin Dermatol. 2013;31(6):772–6.

    Article  PubMed  Google Scholar 

  31. Cheung RY, Cohen JC, Illingworth P. Orphan drug policies: implications for the United States, Canada, and developing countries. Health Law J. 2004;12:183–200.

    PubMed  Google Scholar 

  32. Senate and House of Representatives of the United States of America in Congress. Rare Diseases Act. 2002;107:107–280.

    Google Scholar 

  33. Santoro FA, Rothe MJ, Strober BE. Ethical considerations when prescribing biologics in dermatology. Clin Dermatol. 2012;30(5):492–5.

    Article  PubMed  Google Scholar 

  34. Perkins AC, Choi JM, Kimball AB. Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology. J Am Acad Dermatol. 2007;56(2):279–84.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, University of Alberta, Edmonton, AB, Canada

    Kevin Yang B.Sc.

  2. Division of Dermatology & Cutaneous Sciences, Department of Medicine, University Dermatology Centre, 2-104 Clinical Sciences Building, Edmonton, AB, Canada, T6G 2G3

    Anil Kurian M.D.

  3. Toronto Dermatology Centre, Toronto, ON, Canada

    Benjamin Barankin M.D., F.R.C.P.C.

Authors
  1. Kevin Yang B.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anil Kurian M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin Barankin M.D., F.R.C.P.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anil Kurian M.D. .

Editor information

Editors and Affiliations

  1. Dermatology, UNC School of Medicine, Chapel Hill, North Carolina, USA

    Adnan Nasir

Glossary

Autonomy

 An ethical principle describing the power that patients have to make their own decisions regarding their own medical care

Beneficence

 An ethical principle describing the physician’s responsibility to act in the best interest of the patient and choose a treatment that would maximize the benefit for the patient

Code of ethics

 A document set out by an organization which acts as a formal reminder for members within the respective organization to maintain ethical practices

Community equipoise

 The idea that there is usually uncertainty or debate among experts regarding the gold standard treatment for a certain disease

Conflict of interest

 An exposure which compromises and biases a physician’s decision making ability

Justice

 An ethical principle suggesting that individuals should have fair access to resources and that these resources be distributed fairly

Medical ethics

 Moral obligations and fundamental rules founded within the medical field

Non-maleficence

 An ethical principle that describes the duty physicians have to minimize harm and risk of harm in their patients

Rare disease

 As per the Rare Diseases Act of 2002, a disease that has a prevalence of less than 200,000 American citizens

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Yang, K., Kurian, A., Barankin, B. (2015). Ethics. In: Nasir, A. (eds) Clinical Dermatology Trials 101. Springer, Cham. https://doi.org/10.1007/978-3-319-09027-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09027-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09026-9

  • Online ISBN: 978-3-319-09027-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation